Activity Preview


2017 VT/VF Summit - Enduring (CME/MOC)

Activity Type:

  • Course

This activity has expired

Release Date: 4/20/2017

Expiration Date: 6/1/2018

  • CME: 6
  • Participation - no CE credit: 6


The 2017 VT/VF Summit provides a state-of-the-art discussion on all aspects of managing patients with arrhythmogenic heart disease. Each session will be structured around a clinical case with audience polling of difficult diagnostic and management decisions. Experts will provide reviews of the latest advances and breakthroughs in the field.

Earn up to 6.0 CME credits and 6.0 MOC points

List Price






Member Allied/Fellows In Training


*Non-Member Allied/Fellows In Training


*If you are a Non-Member Allied Professional / Fellow In Training, please Contact Us for special pricing. Please include your title, facility name and complete contact information.


VT01 - Sudden Death and Ventricular Arrhythmias in Coronary Artery Disease
Session Description: This session will review the latest information on ventricular tachycardia and sudden death mechanisms, risk assessment, and management in patients with coronary artery disease.
VT02 - Sudden Death In Patients Without Structural Heart Disease
Session Description: This session will review the latest information on sudden death syndromes in the context of an illustrative case.
VT03 - Arrhythmogenic Cardiomyopathies
Session Description: This session reviews recognition of cardiomyopathies that have a predisposition to arrhythmias, and the mechanisms and management of those arrhythmias.


Learning Objectives

Upon completion of this educational activity, participants will be able to:

  1. Discuss management of VT in post MI patients
  2. Identify epidemiology and risk predictors following a MI
  3. Assess the value and tradeoffs in risk prediction tests
  4. Define the role of molecular diagnostics in patients with VT
  5. Recognize the spectrum of disorders leading to VT without structural heart disease
  6. Explain the work-up of patients with VT and no structural heart disease
  7. Understand current and investigational management options to prevent recurrent arrhythmias in arrhythmogenic cardiomyopathies, including catheter ablation, autonomic moducation and gene therapy
  8. State the pathophysiology of AVRC and inflammatory cardiomyopathies
  9. Understand the mechanisms governing risk of VT due to scars

Access Activity

Target Audience

Clinical Cardiac EPs
Allied Professionals
Directors of EP Labs
EP Fellows


Natalia Trayanova PhD, FHRS
Johns Hopkins University
Baltimore, MD

Christine Albert MD
Brigham and Women's Hospital
Boston, MA

Roderick Tung MD, FHRS
The University of Chicago Medicine
Chicago, IL

George Klein MD
University of Western Ontario
London, ON

Pramesh Kovoor MBBS, FRACP, PhD
Westmead Hospital
Sydney, Australia

John Sapp MD, FHRS
Queen Elizabeth II Health Sciences Centre
Halifax, NS

Dan Roden MD, FHRS
Vanderbilt University
Nashville, TN

Ciorsti MacIntyre MD
QEII Health Sciences Centre
Halifax, NS

Josep Brugada Terradellas MD, PhD
Hospital Clinic - University of Barcelona
Barcelona, Spain

Jeanne Poole MD, FHRS, CCDS
University of Washington
Seattle, WA

Michael Ackerman MD, PhD
Mayo Clinic
Rochester, MN

Mélèze Hociniz, MD
Hôpital Haut-Lévêque
Bordeaux-Pessac, France

Arthur Wilde MD, PhD
University of Amsterdam
Amsterdam, Netherlands

Usha Tedrow MD, MS, FHRS
Brigham and Women's Hospital
Boston, MA

Katja Zeppenfeld MD, PhD
Leiden University Medical Center
Leiden, Netherlands

Hugh Calkins MD, FHRS, CCDS
Johns Hopkins University
Baltimore, MD

Saurabh Kumar BSc(Med), MBBS, PhD
Westmead Hospital, University of Sydney
Westmead, Australia

Marmar Vaseghi MD, MS, FHRS
University of California - Los Angeles
Los Angeles, CA

William Sauer MD, FHRS, CCDS
University of Colorado
Aurora, CO

J. Kevin Donahue MD
University of Massachusetts Medical School
Worcester, MA

Calum MacRae MD
Brigham and Women's Hospital
Boston, MA

CME Information

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Heart Rhythm Society designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Faculty Disclosures


It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflicts of interest related to the content in his/her presentation(s) and also disclose discussions of unlabeled/unapproved uses of drugs or devices during his/her presentation(s).

Faculty Disclosure List PDF


Allegations of conflict of interest and bias are taken seriously and are investigated by the Ethics Oversight Committee, Scientific Sessions Program Committee and/or the Education Committee. Your complaint will be referred to the appropriate committee, and you will be informed in writing of the outcome of its review and decision. Submit a confidential complaint by completing the form at or submit an email message to